According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$73.65 Million a decrease over its 2022 earnings that were of -C$59.93 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -C$48.77 Million | -33.78% |
2023 | -C$73.65 Million | 22.9% |
2022 | -C$59.93 Million | -34.91% |
2021 | -C$92.06 Million | 17.36% |
2020 | -C$78.45 Million | 107.65% |
2019 | -C$37.78 Million | -7.73% |
2018 | -C$40.95 Million | 160.68% |
2017 | -C$15.71 Million | -20.27% |
2016 | -C$19.7 Million | 28.71% |
2015 | -C$15.31 Million | |
2013 | -C$8.68 Million | |
2010 | -C$7.39 Million | -8.31% |
2009 | -C$8.06 Million | |
2006 | -C$14.95 Million | -156.93% |
2005 | C$26.24 M | -185.16% |
2004 | -C$30.82 Million | 458.58% |
2003 | -C$5.52 Million | -63.66% |
2002 | -C$15.19 Million | -8.04% |
2001 | -C$16.51 Million | 16.73% |
2000 | -C$14.15 Million | 294.99% |
1999 | -C$3.59 Million | -6.51% |
1998 | -C$3.83 Million |